A Phase 3 interventional study of Transcranial Direct Current Stimulation and Virtual reality in Stroke Rehabilitaion and Stroke, sponsored by King Saud University. Recruiting at 2 sites in Saudi Arabia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-08.
Sponsored by King Saud University · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 30 studies in Stroke with a site in Saudi Arabia — 10 open to participants now, 11 under way, 1 of them phase 3. Stroke · Saudi Arabia.
Among the 30 studies in Stroke with a site in Saudi Arabia, this one is the 3rd largest by planned enrollment of the 27 interventional ones that give a count, is one of 5 that started in 2023, is one of 2 in phase 3, reaches primary completion later than 3 of the 10 other live ones, and was the 23rd registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →10 of the 30 studies in Stroke with a site in Saudi Arabia are open now. Recruiting first, the newest first:
King Saud University · Sites in Saudi Arabia
Ages 18+
University of Jazan · Sites in Saudi Arabia
Ages 45–65
University of Jazan · Sites in Saudi Arabia
Ages 45–65
University of Jazan · Sites in Saudi Arabia
Ages 45–65
King Saud University · Sites in Saudi Arabia
Ages 18+
A study can be open while its sites in Saudi Arabia have not opened yet or have stopped. Only those recruiting at a site in Saudi Arabia →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
30 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 5 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 300 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 40 across the 27 interventional studies, 2,101 across the 3 observational. Of the 17 that completed or were terminated, 3 (18%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 30 have an industry lead sponsor. The 10 most frequent:
King Saud University is the lead sponsor of 169 studies on the registry; 22 are open to participants now.
King Saud University has 9 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
4 of the studies in Stroke with a site in Saudi Arabia that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07288385King Saud UniversityInvestigating the Feasibility of Combining Virtual Reality and Bilateral Transcranial Direct Stimulation to Improve Upper Limb Recovery in Patients With Stroke | 2026-12-30 |
| NCT07243314King Saud UniversityEvaluating Functional Outcomes of 3D-Printed Splints in Post-Stroke Upper Limb Recovery | 2027-09-30 |
| NCT07914413Umm Al-Qura UniversityFoot Drop Rehabilitation and Mobility in Chronic Stroke | 2027-10 |
| NCT07623018University of ExeterThe Feasibility and Acceptability of a Gait Training Program Based on Telerehabilitation After Stroke | 2027-10-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 30 studies in Stroke with a site in Saudi Arabia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will investigate whether combining virtual reality-based mirror therapy (VRMT) and transcranial direct current stimulation (tDCS) alongside conventional physical therapy (CPT) will significantly improve hand function for patients with stroke compared to using VRMT or tDCS alone.
More than half of stroke survivors suffer from upper-limb dysfunction that persists years after stroke, negatively impacting patients' independence and, therefore, affecting their quality of life. Motor rehabilitation is required after a stroke to facilitate motor recovery. More importantly, finding new ways to maximize patients' motor recovery is a core goal of stroke rehabilitation. Thus, researchers have explored the potential benefits of using advanced technologies such as virtual reality-based mirror therapy (VRMT) and transcranial direct current stimulation (tDCS) to boost the brain's responses to interventions and maximize the effects of rehabilitation to improve upper-limb recovery post-stroke. However, the potential impact of combining VRMT and tDCS on upper limb functions for patients with stroke has not been explored. Therefore, the goal of this study is to investigate whether combining virtual reality-based mirror therapy (VRMT) with transcranial direct current stimulation (tDCS) alongside conventional physical therapy (CPT) will significantly improve hand function for patients with stroke compared to using VRMT or tDCS alone.
The participants will be randomly assigned into one of the four groups: (1) the anodal tDCS + VRMT group, (2) the anodal tDCS alone group, (3) the VRMT alone with sham tDCS group, and (4) the CPT with sham tDCS group. All groups will receive CPT as part of the treatment. Functional scales will be used before and after the intervention to assess upper motor functions. These measures include the Fugl-Meyer Assessment, Wolf Motor Function Test, Box and Block Test, Nine-Hole Pegboard Test, and Stroke Impact Scale-16 (SIS-16). In addition, physiological measures such as transcranial magnetic stimulation (TMS) and task-based fMRI.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
20 minutes of anodal tDCS combined with 45 minutes of VRMT
Device: Transcranial Direct Current Stimulation compined with virtual reality based mirror therapy
20 minutes of anodal tDCS alone
Device: Transcranial Direct Current Stimulation
45 minutes of VRMT alone, For the sham-tDCS, the current flow will be terminated after 30 seconds.
Device: Virtual reality
45 minutes of conventional physical therapy, For the sham-tDCS, the current flow will be terminated after 30 seconds.
Other: Conventional physical therapy
tDCS will be used during the sessions. The anodal tDCS (2 mA) will be applied for 20 minutes. Continuous, direct currents. The anodal electrode will be positioned over the ipsilesional primary motor cortex (M1) (C3 or C4, international 10-20 system) of the affected hemisphere and the cathodal electrode over the contralateral orbit.
The VRMT group will receive VRMT game-based training using their non-affected upper limb. using a semi-immersive motion-tracking device.
20 minutes of tDCS during 45 minutes of VRMT games.
45 minutes of conventional physical therapy with sham tDCS
Fugl-Mayer Upper limb assessment (FMA)
FMA is a performance-based impairment measure particular to strokes, designed to assess motor functioning, balance, sensory, and joint functionality. It consists of five domains, which have 155 total items. The full potential scale score is 226. Scale items are scored based on the ability to finish the item using a 3-point ordinal scale. Motor score: from 0 to 100, 66 points for the upper extremity and 34 points for the lower extremities.
Time frame: at baseline, and after 2 weeks, and after intervention ( 4 weeks).
Wolf motor function test (WMT)
WMT, consisting of timed and practical tasks, measures the motor function of the upper extremity (UE). The WMFT has 17 items in the most common version. The first six items involved timed functional tasks; items 7 and 14 were strength tests, and the final nine analyzed the participants' movement quality while carrying out various tasks. Items scored on a 6-point scale, with lower scores indicating lower levels of functioning.
Time frame: at baseline, and after 2 weeks, and after intervention ( 4 weeks).
box and blocks test (BBT)
BBT assesses manual dexterity of the hand. It requires subjects to lift and release 2.5 cm³ cubes to move them from one compartment to another. BBT comprises 150 blocks. The test should begin with the unaffected upper limb to practice and record baseline values. The score is defined as the number of blocks transferred correctly within 60 seconds.
Time frame: at baseline, and after 2 weeks, and after intervention ( 4 weeks).
Nine-Hole Peg Test (NHPT)
NHPT was developed to assess finger dexterity. It is made up of a nine-peg square board. The board has holes on one end for the pegs to fit into, and it also has a shallow circular dish on the other for storing the pegs. The patient is instructed to quickly insert the pegs into the holes on the board after taking each one out of a container as part of the NHPT. Then, one by one, clients must bring the pegs out of the holes and put them back into the container. Scoring is according to how long it took them to finish the test activity, measured in seconds.
Time frame: at baseline, and after 2 weeks, and after intervention ( 4 weeks).
Stroke impact scale-16 (SIS-16)
SIS is a self-report health status measure specific to the stroke population. It consists of 16 items from the four physical domains (strength, hand function ADL/IADL, and mobility).
Time frame: at baseline, and after 2 weeks, and after intervention ( 4 weeks).
transcranial magnetic stimulation (TMS)
TMS measures cortical excitability, which is non-invasive magnetic stimulation using brief-duration, fast-pulsating, or pulsed magnetic fields to induce electrical currents targeted at spatially separate parts of the cerebral cortex using a computerized, electromechanical medical device.
Time frame: at baseline, and after intervention ( 4 weeks).
Functional magnetic resonance imaging (fMRI)
fMRI technique uses MRI technology to evaluate brain activity by looking for variations in blood flow. The coupling between cerebral blood flow and neuronal activation is the basis for this method. The participants will be trained on the task before the experimental session. A block design will be used in the fMRI scan; each fMRI scan lasts for 6 minutes, divided into six blocks with an interval of 30 seconds of task, 15 repeated contractions, each contraction lasting 2 seconds, interspersed with 30 seconds of rest.
Time frame: at baseline, and after intervention ( 4 weeks).
Started Sep 2023 (actual). Primary completion is estimated for May 2025, 20 months after the start.
Of 93 non-industry phase 3 interventional studies under Stroke, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 71. This study's planned 20 months is below that.
Counting every sponsor, half of 130 studies reached it within 44 months; a quarter within 27 and three quarters within 68.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.